In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on Inotiv (NOTV – Research Report). The company’s shares closed yesterday at $5.02.
According to TipRanks, Hewitt is a 4-star analyst with an average return of 5.7% and a 50.00% success rate. Hewitt covers the Healthcare sector, focusing on stocks such as Apyx Medical, Ligand Pharma, and Societal CDMO.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Inotiv with a $8.00 average price target.
See the top stocks recommended by analysts >>
Based on Inotiv’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $122.75 million and a GAAP net loss of $87.32 million. In comparison, last year the company earned a revenue of $84.21 million and had a GAAP net loss of $83.05 million
Based on the recent corporate insider activity of 27 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of NOTV in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Bioanalytical Systems, Inc. operates as a pharmaceutical development company, which engages in the provision of drug discovery, development services, and analytical instruments. The firm operates through the following business segments: Contract Research Services and Research Products. The Contract Research Services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing. The Research Products segment designs, develops, manufactures, and markets vivo sampling systems and accessories, physiology monitoring tools, liquid chromatography, and electrochemistry instruments platforms. The company was founded by Peter T. Kissinger in 1974 and is headquartered in West Lafayette, IN.
Read More on NOTV:
